American Journal of Epidemiology Vol. 118, No. 2: 206-212
Copyright © 1983 by The Johns Hopkins University School of Hygiene and Public Health
other |
INCIDENCE ESTIMATES FOR LENS CHANGES, MACULAR CHANGES, OPEN-ANGLE GLAUCOMA AND DIABETIC RETINOPATHY
1Office of Biometry and Epidemiology, National Eye Institute, National Institutes of Health Building 31, Room 6A18, Bethesda, MD 20205
2Department of Commmunity and Preventive Medicine, School of Medicine, State University of New York at Stony Brook Stony Brook, NY
Reprint requests to Mr. Podgor.
Podgor, M. J. (National Eye Institute, NIH, Bethesda, MD 20205), M. C. Leske and F. Ederer. Incidence estimates for lens changes, macular changes, open-angle glaucoma and diabetic retinopathy. Am J Epidemiol 1983; 118: 206–12.
Incidence data are lacking for common eye conditions. The authors previously developed a method for estimating incidence from age-specific prevalences for diseases that are Irreversible and not associated with differential mortality (Am J Epidemiol 1981; 113: 606–13). This method is now used to estimate age-specific incidences for senile lens changes, senile cataracts, macular changes, senile macular degeneration, open-angle glaucoma, and diabetic retinopathy. Using age-specific prevalence data from the Framingham Eye Study, five-year incidence rates were estimated for ages 55, 60, 65, 70, and 75. For each condition, estimated incidence increased with age: incidence estimates ranged from 10% to 37% for senile lens changes, from 1% to 15% for senile cataracts, from 3% to 6% for macular changes, from 0.5% to 7% for senile macular degeneration, from 0.2% to 1% for open-angle glaucoma, and, among diabetics, from 3% to 5% for diabetic retinopathy. Standard errors were small for senile lens changes and senile cataracts, but large (of about the same magnitude as the incidence estimates) for macular changes, senile macular degeneration, open-angle glaucoma, and diabetic retinopathy. These estimates may be useful as approximations of the true incidence rates in planning epidemiologic research.
biometry; cataract; diabetic retinopathy; epidemiologic methods; glaucoma; macular degeneration; research design
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. A. McKinzie, J. P. Reinhardt, and D. Benn Adaptation to Chronic Vision Impairment: Does African American or Caucasian Race Make a Difference? Research on Aging, March 1, 2007; 29(2): 144 - 162. [Abstract] [PDF]
|
|
|
|
 |
|
 L. M. Zangwill, R. N. Weinreb, C. C. Berry, A. R. Smith, K. A. Dirkes, A. L. Coleman, J. R. Piltz-Seymour, J. M. Liebmann, G. A. Cioffi, G. Trick, et al. Racial Differences in Optic Disc Topography: Baseline Results From the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study Arch Ophthalmol, January 1, 2004; 122(1): 22 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Sloan, D. S. Brown, E. S. Carlisle, J. Ostermann, and P. P. Lee Estimates of Incidence Rates With Longitudinal Claims Data Arch Ophthalmol, October 1, 2003; 121(10): 1462 - 1468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I Kocur and S Resnikoff Visual impairment and blindness in Europe and their prevention Br. J. Ophthalmol., July 1, 2002; 86(7): 716 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-Y. Wu, B. Nemesure, and M. C. Leske Observed versus Indirect Estimates of Incidence of Open-Angle Glaucoma Am. J. Epidemiol., January 15, 2001; 153(2): 184 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Leske, A. M. S. Connell, S.-Y. Wu, B. Nemesure, X. Li, A. Schachat, A. Hennis, and for the Barbados Eye Studies Group Incidence of Open-Angle Glaucoma: The Barbados Eye Studies Arch Ophthalmol, January 1, 2001; 119(1): 89 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Musch Insights From Incidence: The Barbados Eye Studies Arch Ophthalmol, January 1, 2001; 119(1): 117 - 118. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Brennan and G. Cardinali The Use of Preexisting and Novel Coping Strategies in Adapting to Age-Related Vision Loss Gerontologist, June 1, 2000; 40(3): 327 - 334. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. H. Gail, J. P. Costantino, J. Bryant, R. Croyle, L. Freedman, K. Helzlsouer, and V. Vogel Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer J Natl Cancer Inst, November 3, 1999; 91(21): 1829 - 1846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. O. Gordon, M. A. Kass, and for the Ocular Hypertension Treatment Study Group The Ocular Hypertension Treatment Study: Design and Baseline Description of the Participants Arch Ophthalmol, May 1, 1999; 117(5): 573 - 583. [Abstract] [Full Text] [PDF]
|
|